BE899293A - Compositions pharmaceutiques a liberation soutenue de theophylline. - Google Patents

Compositions pharmaceutiques a liberation soutenue de theophylline.

Info

Publication number
BE899293A
BE899293A BE0/212666A BE212666A BE899293A BE 899293 A BE899293 A BE 899293A BE 0/212666 A BE0/212666 A BE 0/212666A BE 212666 A BE212666 A BE 212666A BE 899293 A BE899293 A BE 899293A
Authority
BE
Belgium
Prior art keywords
theophyllin
pharmaceutical compositions
sustained release
release pharmaceutical
theophylline
Prior art date
Application number
BE0/212666A
Other languages
English (en)
Original Assignee
Elan Corp Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Corp Plc filed Critical Elan Corp Plc
Publication of BE899293A publication Critical patent/BE899293A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un granule à absorption soutenue de théophylline constitué d'un noyau de théophylline ou d'un équivalent pharmacologique de cette dernière et d'un acide organique noyé dans une matière polymère en couches multiples et d'une membrane externe qui permet la libération de la théophylline à vitesse réglée en milieu aqueux.
BE0/212666A 1983-04-06 1984-03-30 Compositions pharmaceutiques a liberation soutenue de theophylline. BE899293A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE789/83A IE55745B1 (en) 1983-04-06 1983-04-06 Sustained absorption pharmaceutical composition

Publications (1)

Publication Number Publication Date
BE899293A true BE899293A (fr) 1984-07-16

Family

ID=11018164

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212666A BE899293A (fr) 1983-04-06 1984-03-30 Compositions pharmaceutiques a liberation soutenue de theophylline.

Country Status (9)

Country Link
US (2) US4663150A (fr)
EP (1) EP0122077B1 (fr)
JP (1) JPS59219219A (fr)
AT (1) ATE53176T1 (fr)
BE (1) BE899293A (fr)
CH (1) CH660688B (fr)
DE (1) DE3482374D1 (fr)
IE (1) IE55745B1 (fr)
PH (1) PH18904A (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
IE58246B1 (en) * 1984-12-21 1993-08-11 Byk Gulden Lomberg Chem Fab Theophylline sustained release formulation
GB2170104A (en) * 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems
US4826688A (en) * 1985-11-13 1989-05-02 501 Elan Corporation PLC. Controlled absorption pharmaceutical formulation
US5026709A (en) * 1986-04-07 1991-06-25 Rorer Pharmaceutical Corporation Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby
IE58401B1 (en) * 1986-06-20 1993-09-08 Elan Corp Plc Controlled absorption pharmaceutical composition
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
GB8628728D0 (en) * 1986-12-02 1987-01-07 Euro Celtique Sa Spheroids
IL84599A0 (en) * 1986-12-09 1988-04-29 Byk Gulden Lomberg Chem Fab Pharmaceutical composition containing urapidil and process for the preparation thereof
US4789549A (en) * 1987-03-09 1988-12-06 Warner-Lambert Company Sustained release dosage forms
CA1323833C (fr) * 1987-04-28 1993-11-02 Yatindra M. Joshi Compositions pharmaceutiques sous forme de granules et methode de fabrication
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4786509A (en) * 1987-05-18 1988-11-22 Schering Corporation Dry sustained release theophylline oral formulation
NZ226575A (en) * 1987-10-16 1991-01-29 Elan Corp Plc Controlled release formulation containing cis-(+)-3-acetyloxy-5-(2-(dimethylamino)ethyl)-2,3 dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepine-4(5h)one(diltiazem) and having a surrounding membrane
IE64726B1 (en) 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
JPH0674206B2 (ja) * 1989-12-28 1994-09-21 田辺製薬株式会社 放出制御型製剤およびその製法
US5162110A (en) * 1990-12-19 1992-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Binding theophylline to ion exchange resins
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
AU2016992A (en) * 1991-05-20 1992-12-30 Marion Laboratories, Inc. Multi-layered controlled release formulation
US5229135A (en) * 1991-11-22 1993-07-20 Prographarm Laboratories Sustained release diltiazem formulation
SE9202250D0 (sv) * 1992-07-29 1992-07-29 Gacell Lab Ab Controlled release morphine preparation
US5744164A (en) * 1994-12-16 1998-04-28 Nestec S.A. Sustained release microparticulate caffeine formulation
US20060068002A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
US5766623A (en) * 1996-03-25 1998-06-16 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Compactable self-sealing drug delivery agents
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US6168801B1 (en) * 1998-09-09 2001-01-02 Cardiac Pacemakers, Inc. Controlled release drug delivery
DE19845358A1 (de) * 1998-10-02 2000-04-06 Roehm Gmbh Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US20040029959A1 (en) * 2002-08-08 2004-02-12 John Devane Isosorbide mononitrate compositions and methods of their use
CN1688292A (zh) * 2002-09-04 2005-10-26 兰贝克赛实验室有限公司 掩味剂型及其制造方法
GB0227948D0 (en) * 2002-11-29 2003-01-08 Cipla Ltd Pharmaceutical combinations comprising b-2 adrenoreceptor agonists and xanthines
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
DE10353196A1 (de) * 2003-11-13 2005-06-16 Röhm GmbH & Co. KG Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix
CA2569961A1 (fr) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc Preparation pharmaceutique a liberation lente
JP2008534530A (ja) * 2005-03-29 2008-08-28 エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング 活性成分放出に関して調節作用を有する物質を有するペレットを含有している多粒子薬剤形
EP1743638A1 (fr) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Formulations pharmaceutiques des derivés de la pyrazoline
WO2007011972A2 (fr) * 2005-07-19 2007-01-25 Inverseon, Inc. Profil pharmocinetique ameliore d'agonistes inverses beta-adrenergiques pour le traitement de maladies des voies aeriennes pulmonaires
CA2640460C (fr) * 2006-01-27 2015-05-26 Eurand, Inc Systeme d'administration de medicaments comprenant un agent selectif, faiblement basique bloquant le 5-ht3 de la serotonine et des acides organiques
BRPI0707325A2 (pt) * 2006-01-27 2011-05-03 Eurand Inc formulação de dosagem de liberação multiparticulada e método para preparação da mesma
ES2385498T3 (es) * 2006-08-18 2012-07-25 Evonik Röhm Gmbh Composición farmacéutica con liberación controlada de la sustancia activa, para sustancias activas con una buena solubilidad en agua
US8133506B2 (en) * 2008-03-12 2012-03-13 Aptalis Pharmatech, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
US8992898B2 (en) 2010-04-17 2015-03-31 Shannon Elizabeth Klingman Antiperspirants and deodorants
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
RS61368B1 (sr) * 2018-09-27 2021-02-26 Inibsa Ginecologia S A Postupak za pripremu višejediničnog oralnog doznog oblika sa modifikovanim oslobađanjem doksilamin sukcinata i piridoksin hidrohlorida
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2853420A (en) * 1956-01-25 1958-09-23 Lowey Hans Ethyl cellulose coatings for shaped medicinal preparations
US3081233A (en) * 1960-08-08 1963-03-12 Upjohn Co Enteric-coated pilules
NL122039C (fr) * 1960-10-20
NL297088A (fr) * 1961-01-31
US3247066A (en) * 1962-09-12 1966-04-19 Parke Davis & Co Controlled release dosage form containing water-swellable beadlet
NL297631A (fr) * 1963-06-03
US3949068A (en) * 1964-02-20 1976-04-06 University Of Alabama In Birmingham Medical And Educational Foundation Pharmaceutical compositions
US3400185A (en) * 1965-04-08 1968-09-03 Bristol Myers Co Agglomeration of smaller pharmaceutical particles into larger microspherules and enteic-coating thereof
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
US3906087A (en) * 1973-09-10 1975-09-16 Union Corp Sustained release of methantheline
US4085214A (en) * 1976-10-18 1978-04-18 Interx Research Corporation Stable pro-drug forms of theophylline
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
US4309406A (en) * 1979-07-10 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4248858A (en) * 1979-08-09 1981-02-03 American Home Products Corporation Sustained release pharmaceutical compositions
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
JPS56122311A (en) * 1980-02-29 1981-09-25 Eisai Co Ltd Lasting theophylline pharmaceutical composition
NZ196349A (en) * 1980-03-07 1984-08-24 Interx Research Corp Enhancement of absorption rate of orally administered polar bioactive agents
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
EP0083372B1 (fr) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Theophylline a liberation prolongee
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
US4415547A (en) * 1982-06-14 1983-11-15 Sterling Drug Inc. Sustained-release pharmaceutical tablet and process for preparation thereof
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
US4710384A (en) * 1986-07-28 1987-12-01 Avner Rotman Sustained release tablets made from microcapsules

Also Published As

Publication number Publication date
CH660688B (fr) 1987-06-15
US4663150A (en) 1987-05-05
JPS59219219A (ja) 1984-12-10
IE55745B1 (en) 1991-01-02
EP0122077A2 (fr) 1984-10-17
DE3482374D1 (de) 1990-07-05
US4820521A (en) 1989-04-11
JPH0466207B2 (fr) 1992-10-22
EP0122077A3 (en) 1985-09-11
EP0122077B1 (fr) 1990-05-30
ATE53176T1 (de) 1990-06-15
PH18904A (en) 1985-10-30

Similar Documents

Publication Publication Date Title
BE899293A (fr) Compositions pharmaceutiques a liberation soutenue de theophylline.
BE899464A (fr) Composition a liberation soutenue de propanolol.
IT8919730A0 (it) Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
BR8700936A (pt) Aparelhagem de fibra optica alongada e sistema sensor para sentir uma caracteristica especificada do conteudo de um fluido
IT8423449A0 (it) Indicatori stabilizzati per rivelare l'attivita' di enzimi e procedimenti per la loro preparazione ed uso.
RU93004786A (ru) Платформа
ES509085A0 (es) "perfeccionamientos en la fabricacion de dispositivos de retencion axial para ejes cilindricos".
IT1233435B (it) Sospensione per la ruota anteriore di motociclette e simili.
FI893325A7 (fi) Suulakepuristettava monen kovuuden hydrodynaaminen laakeri ja menetelmä sen valmistamiseksi
BR8501627A (pt) Processos para preparacao de tartarato oticamente ativo de di-(3-cloro-2-oxi-propiltrimetilaminio),e cloreto nitrilico de carnitina oticamente ativo
FI833655A0 (fi) Fog foer sammanfogning av traebalkar och fogens anvaendning vid takstolskonstruktionen
ITRM910490A1 (it) Struttura di fibre di rinforzo, da usare per la fabbricazione di travi, telai e simili
DE69120257D1 (de) Sphärische hydraulische substanz und ihre herstellung
IT8219359A0 (it) Macchina per la produzione di corpi tubolari in materiali flessibili, come cartone e simili.
IT8805215A0 (it) Girello per bambini con sistema di arresto in presenza di gradini o dislivelli.
ES535697A0 (es) Perfeccionamientos en la fabricacion de microcapsulas
ES513956A0 (es) "procedimiento para la carbonilacion de olefinas y esteres organicos".
ES508153A0 (es) "perfeccionamientos introducidos en la estructura y fabricacion de bastidores para silenciador".
ES514943A0 (es) Perfeccionamientos en la construccion de tractores.
ES510647A0 (es) "procedimiento para la preparacion de acido fluorhidrico y co y-o co2 a partir de compuestos organicos fluorados".
IT8522618A0 (it) Sistema per la costruzione di dighe a scalini, a modo di gradinata e/o mosaico, ad uso ricreativo.
IT8420990A1 (it) "Nuovo sistema adatto all'impiego nella determinazione dell'attività degli antibiotici o simili"
IT1102696B (it) Sistema costruttivo per la costruzione di balconi o simili con l'impiegeo di elementi modulari parzialmente prefabbricati ed elementi pre fabre kicati utilizzati
IT8912009A0 (it) Sistema per ristabilire l'equilibrio marino mediante la coprecipitazione del fosforo e delle alghe
JPS6329106U (fr)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELAN CORP. P.L.C.

Effective date: 19990331